# Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery

> **NCT04542759** · PHASE1 · COMPLETED · sponsor: **Instituto de Oftalmología Fundación Conde de Valenciana** · enrollment: 60 (actual)

## Conditions studied

- Microbial Disease
- Cataract Senile

## Interventions

- **DRUG:** Besifloxacin Ophthalmic
- **DRUG:** Hydroxypropyl Methylcellulose Ophthalmic Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04542759
- **Lead sponsor:** Instituto de Oftalmología Fundación Conde de Valenciana
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542759, "Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04542759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*